This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Updates Pharmacology : Olaf van Tellingen group

Pint of Science Festival

The Pint of Science festival aims to deliver interesting, fun, relevant talks on the latest science research in an accessible format to the public - all in the pub! During the upcoming edition on May 20th, Paul Slangen, Mark de Gooijer and Inge Verbrugge will be hosting an evening themed 'The Brain: can we beat this obstacle course?'.

The event is freely admissible, but registration is required and can be done by following the link below. We hope to see you all there!


The Brain: can we beat this obstacle course?

Thesis Mark de Gooijer

On Wednesday January 23rd, 2019, Mark de Gooijer defended his thesis in Pharmaceutical Sciences at the University of Utrecht and was honoured with a cum laude distinction. He was also awarded a silver UIPS medal.

Mounting an attack on the glioblastoma triad: proliferation, invasion and resistance.

Malignant brain tumors respond very poorly to treatment because of uncontrolled cell proliferation, strong invasiveness and resistance to therapy. PhD researcher Mark de Gooijer has shown that, although new treatments can efficiently attack each of these problems separately, combining them will be necessary to provide better prognoses for patients with brain tumors.

De Gooijer, MarkMark de GooijerPostdoc

Grant Stichting Stophersentumoren

We have received a research grant from the Stichting Stophersentumoren, which is being used to for a preclinical proof-of-concept study to assess whether we can improve the therapy of glioblastoma by inhibition of glioma invasion.

Grant Stichting Aniek Hendriksz Second to None

We have received a grant of Stichting Aniek Hendriksz Second to None, which is being used to design and test the use of therapies with clever combinations of targeted agents.

Back to group page


  • Office manager

    Thea Eggenhuizen

  • E-mail

  • Telephone Number


Eggenhuizen, Thea.jpg
Share this page